/ --
Key Highlights of the research paper
This novel research has shown positive effects of three new, high-dilution potentized homeopathic medicines, which are often criticized for lack of scientific evidence. The unique process called homeopathic potentization renders the drugs to be safe yet effective. The development has been lauded as the first-of-its-kind in over fifty years in the field of homeopathy. Dr. Rajesh Shah, the brain behind this path-breaking study was feted with the National Award by the Ministry of AYUSH last year for another drug-discovery,
Dr. Rajesh Shah sharing his insight on the research said, "I have been working on developing new homeopathic drugs. Our studies have shown the killing of cancer cells (apoptosis) as well as inhibition of the growth of cancer cells in different laboratory models. The drugs show anti-cancer activity on cell lines related to the liver, cervix, breast, and lung cancers. Earlier, HIV Nosode and Hepatitis C Nosode have also shown anti-cancer effects in studies in coordination with Dr. A.R. Khuda-Bukhsh, an eminent molecular biologist from Kalyani University, West Bengal. The development process started 15 years ago. I believe the initial results are encouraging."
Dr. Vedang Murthy, a radiation oncologist and researcher at Tata Memorial Hospital Mumbai, observed, "Cancer is a very difficult disease to treat and we are always on the lookout for new approaches in its treatment. Early research in the laboratory with a drug prepared from cancer tissues has shown activity against cancer cells. Dr. Shah has shown preliminary results which should be strengthened by further research. These results may indicate some efficacy of homeopathy in the laboratory model. This seems like an early exploration of untapped potential of homeopathy against cancer."
References:
Peer-reviewed articles links:
1. Peer reviewed journal in Brazil: https://www.highdilution.org/index.php/ijhdr/article/view/912
2. Peer reviewed journal in Brazil: https://www.highdilution.org/index.php/ijhdr/article/view/913
3. Peer reviewed journal by Govt. of India: http://www.ijrh.org/article.asp?issn=0974-7168;year=2015;volume=9;issue=1;spage=25;epage=33;aulast=Shah
Other relevant peer-reviewed publications:
1. https://www.ncbi.nlm.nih.gov/pubmed/29157470
2. https://www.sciencedirect.com/science/article/abs/pii/S2095496416602510
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
